Head Start 2024


  • Leonardo Hotel Hinckley Island
  • Sunday 09 & Monday 10 June 2024
  • Register here*

This meeting is organised and funded by Teva UK Limited. Views provided by speakers are their own and not necessarily shared by Teva UK Limited. Information at the meeting may discuss drug classes where Teva has a product. Prescribing information will be available at the meeting. The event is open to HCPs from the UK and Ireland with an interest in headache and migraine. *This link will direct you to a promotional webpage.

Teva UK Limited is excited to open registrations for the sixth Head Start meeting taking place on Sunday 09 and Monday 10 June 2024 at the Leonardo Hotel Hinckley Island.

Join us to stay engaged in the latest discussions on the management of headache and migraine. The agenda has been developed by a specialist Steering Committee comprised of Dr Mona Ghadiri-Sani, Professor Peter Goadsby, Dr Krishna Dani, Dr Edward O’Sullivan, Dr Vivek Mehta and Mrs Claire Fisher.

The agenda includes talks from leading specialists, engaging live panel discussions and interactive clinical case studies. Notable highlights include:

  • Exploring the current headache landscape: what do the new guidelines mean for patient practice?
  • Under pressure: Investigating the current management of low pressure headaches
  • Exploring predictors of response to anti-CGRP monoclonal antibodies: latest clinical evidence
  • Cracking complex cases: complexities of comorbidities in headache

Interested in attending? Register here now*

Places at this meeting are limited, your place is not secured until confirmed by the meeting Secretariat.

Adverse events should be reported. Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard for the UK and at http://www.hpra.ie for the ROI.
Adverse events should also be reported to Teva UK Limited on +44 (0) 207 540 7117 or medinfo@tevauk.com

This promotional meeting is organised and funded by Teva UK Limited
D: AJO-GB-00378 / T: AJO-GB-00397/ M: AJO-GB-00398
Date of Preparation: March 2024
Teva UK Limited, Ridings Point, Whistler Drive, Castleford, WF10 5HX